Press Releases

INOVIO to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Posted on August 29, 2023

INOVIO Announces Second Quarter 2023 Financial Results and Provides Strategic Update

Posted on August 9, 2023

INOVIO to Report Second Quarter 2023 Financial Results on August 9, 2023

Posted on July 26, 2023

INOVIO Announces Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions

Posted on June 23, 2023

INOVIO to Present at the 2023 Jefferies Healthcare Conference

Posted on May 25, 2023

INOVIO Announces Orphan Drug Designation for INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis from the European Commission

Posted on May 23, 2023

INOVIO Reports First Quarter 2023 Financial Results and Operational Highlights

Posted on May 10, 2023

New Data from Phase 1/2 Trial of INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis Presented at ABEA during COSM 2023

Posted on May 8, 2023

INOVIO to Present at the 2023 RBC Capital Markets Global Healthcare Conference

Posted on May 5, 2023

INOVIO to Report First Quarter 2023 Financial Results on May 10, 2023

Posted on April 28, 2023

© Copyright 2025 INOVIO Pharmaceuticals. All rights reserved.